Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial

• Үндсэн зохиолчид: Yaoliang Lai (Зохиогч), Xiao Liang (Зохиогч), Heng Fan (Зохиогч), Yujin Liu (Зохиогч), Liang Zheng (Зохиогч), Weimin Lu (Зохиогч), Yuling Sun (Зохиогч), Dawei Huang (Зохиогч), Xingxing Liu (Зохиогч), Lijian Zhang (Зохиогч), Dongmei Zuo (Зохиогч), Zhexing Shou (Зохиогч), Qing Tang (Зохиогч), Yuanyuan Wang (Зохиогч), Zhen Li (Зохиогч), Zhengyan Jiang (Зохиогч), Shuo Zang (Зохиогч), Huisuo Huang (Зохиогч), Zongxiang Tang (Зохиогч), Qian Li (Зохиогч), Jun Xiao (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Elsevier, 2022-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Diarrhea predominant irritable bowel syndrome (IBS) is a highly relapsing gastrointestinal disorder decreasing the quality of life. Existing studies indicated that the therapeutic effects maintained for a period of time after the treatments were discontinued (post-treatment therapeutic effects or PT...